NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,673,662 | +18.2% | 16,431 | +17.1% | 0.05% | +10.4% |
| Q2 2023 | $1,416,070 | +96.0% | 14,033 | +78.7% | 0.05% | +65.5% |
| Q1 2023 | $722,324 | +3.5% | 7,851 | +2.1% | 0.03% | -17.1% |
| Q4 2022 | $697,592 | +25.5% | 7,690 | +5.1% | 0.04% | +9.4% |
| Q3 2022 | $556,000 | -14.9% | 7,320 | -5.2% | 0.03% | -13.5% |
| Q2 2022 | $653,000 | -16.7% | 7,724 | -13.6% | 0.04% | -5.1% |
| Q1 2022 | $784,000 | +9.7% | 8,936 | +9.3% | 0.04% | +14.7% |
| Q4 2021 | $715,000 | -4.7% | 8,178 | -10.8% | 0.03% | -19.0% |
| Q3 2021 | $750,000 | -45.1% | 9,165 | -38.8% | 0.04% | -49.4% |
| Q2 2021 | $1,367,000 | -3.1% | 14,981 | -9.2% | 0.08% | -15.3% |
| Q1 2021 | $1,411,000 | -1.6% | 16,503 | +8.6% | 0.10% | -7.5% |
| Q4 2020 | $1,434,000 | -99.7% | 15,192 | +182.2% | 0.11% | +158.5% |
| Q3 2020 | $468,000,000 | – | 5,384 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |